4600-97-9

Usage

Uses

Used in Pharmaceutical Research:
DSP-4 is utilized as a selective noradrenergic neurotoxin for the purpose of studying the noradrenergic system's role in various physiological and pathological conditions. It is instrumental in creating animal models that mimic neurodegenerative diseases and psychiatric disorders, allowing researchers to explore potential treatments and understand the underlying mechanisms of these conditions.
Used in Neurodegenerative Disease Research:
In the field of neurodegenerative disease research, DSP-4 is employed as a tool to selectively lesion noradrenergic neurons. This selective lesioning helps researchers investigate the impact of noradrenergic system degeneration on the development and progression of diseases such as Parkinson's disease, providing insights into potential therapeutic targets and interventions.
Used in Psychiatric Disorder Research:
DSP-4 is also used in psychiatric disorder research as a means to induce noradrenergic system alterations in animal models. This allows scientists to study the relationship between the noradrenergic system and psychiatric conditions, such as depression and anxiety, and to evaluate the effectiveness of various treatment strategies.
Used in Toxicology Studies:
DSP-4 serves as a model compound in toxicology studies, where it is used to investigate the effects of neurotoxins on the central nervous system. This research is crucial for understanding the mechanisms of neurotoxicity and for developing strategies to protect against or mitigate the damage caused by such toxins.

InChI:InChI=1/C13H16ClN.ClH/c14-8-11-15-9-6-13(7-10-15)12-4-2-1-3-5-12;/h1-6H,7-11H2;1H